# Exploring the ALS Multistep Model

**Authors:** Andrew Eisen

PMC · DOI: 10.3390/brainsci16020236 · Brain Sciences · 2026-02-18

## TL;DR

The paper proposes a multistep model for ALS, suggesting that environmental factors and aging contribute to disease progression and that early interventions may prevent it.

## Contribution

The novel contribution is the multistep model of ALS that integrates genetics, environment, and aging to rethink prevention and treatment strategies.

## Key findings

- Environmental exposures act as modifiers that influence ALS progression by accelerating step accumulation.
- The multistep model suggests that protecting neurodevelopment and using anti-aging agents may prevent ALS.
- Therapies targeting single pathways are insufficient; instead, interventions should focus on multiple steps and timing.

## Abstract

What are the main findings?
Combined environmental exposures act as modifiers to induce new steps in ALS.The multistep model encourages rethinking of therapeutic strategies in ALST.

Combined environmental exposures act as modifiers to induce new steps in ALS.

The multistep model encourages rethinking of therapeutic strategies in ALST.

What are the implications of the main findings?
ALS may be preventable by protecting neurodevelopment and using anti-aging agents.Neurons and glia ecosystem are rescuable.

ALS may be preventable by protecting neurodevelopment and using anti-aging agents.

Neurons and glia ecosystem are rescuable.

ALS is a multistep disease, in which (epi)genetic, environmental, and age-related processes, including senescence, converge over decades to reduce resilience resulting in self-sustaining symptomatic disease. The multistep model visualizes five to six impactful events in sporadic ALS, but fewer in those carrying high-penetrance mutations, such as SOD1, FUS, or C9orf72 expansions. The timing, duration, and cumulative effects of specific steps are presumed to have individual variability but, the steps themselves are inferred since they have not been observed and remain agnostic as to biological identity. Nevertheless, the model gives an opportunity to integrate genetics, aging, environmental exposures, and systems-level vulnerability into a single framework. Acting as step modifiers, environmental exposures including trauma lower the threshold for step acquisition, accelerate the accumulation of steps, influence the anatomical site of disease onset, and unmask preclinical disease. Because ALS emerges from the gradual collapse of multiple layers of biological robustness, tackling a single pathway will be insufficient and the multistep model forces a reconsideration of therapeutic timing and strategies. Protection against early-life insults, anti-aging, and anti-senescent therapies may curtail step accumulation preventing ALS from exceeding threshold and disease manifestation.

## Linked entities

- **Genes:** SOD1 (superoxide dismutase 1) [NCBI Gene 6647], FUS (FUS RNA binding protein) [NCBI Gene 2521], C9orf72 (C9orf72-SMCR8 complex subunit) [NCBI Gene 203228]
- **Diseases:** ALS (MONDO:0004976)

## Full-text entities

- **Genes:** SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, C9orf72 (C9orf72-SMCR8 complex subunit) [NCBI Gene 203228] {aka ALSFTD, DENND9, DENNL72, FTDALS, FTDALS1}, FUS (FUS RNA binding protein) [NCBI Gene 2521] {aka ALS6, ETM4, FUS1, HNRNPP2, POMP75, TLS}, TARDBP (TAR DNA binding protein) [NCBI Gene 23435] {aka ALS10, TDP-43}
- **Diseases:** infection (MESH:D007239), neurotoxic (MESH:D020258), synapse loss and functional decline (MESH:D060825), cancer (MESH:D009369), Huntington's (MESH:D006816), neuroinflammation (MESH:D000090862), insulin resistance (MESH:D007333), chronic inflammation (MESH:D007249), neurodegeneration (MESH:D019636), Trauma (MESH:D014947), Amyotrophic lateral sclerosis (MESH:D000690), head injury (MESH:D006259), mitochondrial (MESH:D028361), genetic defect (MESH:D030342), frontotemporal dementia (MESH:D057180), immune dysregulation (OMIM:614878), spinal trauma (MESH:D013119), acute infections (MESH:D000208), ALS (MESH:D008113), chronic (MESH:D002908), sporadic disease (MESH:D020821), degeneration (MESH:D009410), falls (MESH:C537863)
- **Chemicals:** STEP (-), polyphenol (MESH:D059808)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** Q331K

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938998/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938998/full.md

## References

105 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938998/full.md

---
Source: https://tomesphere.com/paper/PMC12938998